HYPERPROGRESSION

Clinical trials for HYPERPROGRESSION explained in plain language.

Never miss a new study

Get alerted when new HYPERPROGRESSION trials appear

Sign up with your email to follow new studies for HYPERPROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can chemotherapy stop immunotherapy from backfiring in lung cancer?

Disease control Not yet recruiting

This study is for people with advanced non-small cell lung cancer (NSCLC) who have a specific biomarker that puts them at high risk for a dangerous side effect called hyperprogression, where immunotherapy can cause tumors to grow much faster. Researchers want to see if starting t…

Matched conditions: HYPERPROGRESSION

Phase: PHASE2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

HYPERPROGRESSION

Get alerted when new HYPERPROGRESSION trials appear

Can chemotherapy stop immunotherapy from backfiring in lung cancer?